Kubica, K., & Mazurek, A. (2016). VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE/THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA. Prospects in Pharmaceutical Sciences, 14(8), 52–56. https://doi.org/10.56782/pps.117